Skip to main content
S&P 5007,720.39-0.30%DOW52,342.56-0.25%NASDAQ26,184.72-1.38%BTC$77,045.00-4.95%ETH$2,215.83-5.85%GOLD$4,026.60-0.12%OIL$102.79+0.77%
Smart Investors Daily
SID Premium
HR

NASDAQ · HRTX

Heron Therapeutics, Inc.

Healthcare · Biotechnology

$0.29

Down-$0.01 (-4.69%)

Updated Oct 30, 2026, 6:06 AM

SID Score

3.3/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
214.8M
P/E ratio
-224.99
Dividend yield
0.00%
52-week range
$0.26 – $1.34
Volume
1.02M
Avg. volume
1.85M

Price performance · HRTX

HRTX price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 29, 2026

HRTX closed at $0.29 after 21 trading sessions, down 17.28% for the selected period.

Last close
$0.29
Period change
-17.28%
Period low
$0.29
Period high
$0.42
Daily close
View OHLC price history
HRTX OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 29, 2026$0.3095$0.3126$0.2915$0.29441.02M
Oct 28, 2026$0.30$0.3101$0.295$0.3089701.73K
Oct 27, 2026$0.301$0.3199$0.2958$0.30151.14M
Oct 26, 2026$0.2988$0.304$0.281$0.30071.06M
Oct 23, 2026$0.2922$0.3085$0.2852$0.30281.31M
Oct 22, 2026$0.3355$0.3469$0.286$0.29624.74M
Oct 21, 2026$0.355$0.3671$0.3319$0.33883.17M
Oct 20, 2026$0.3616$0.3859$0.3529$0.35451.48M
Oct 19, 2026$0.364$0.3752$0.3482$0.36091.58M
Oct 16, 2026$0.38$0.385$0.3502$0.3611.74M
Oct 15, 2026$0.3714$0.40$0.3601$0.37651.28M
Oct 14, 2026$0.3809$0.395$0.357$0.3622.09M
Oct 13, 2026$0.4201$0.4266$0.38$0.39061.87M
Oct 12, 2026$0.40$0.4246$0.38$0.41561.96M
Oct 9, 2026$0.3537$0.41$0.3501$0.40613.5M
Oct 8, 2026$0.373$0.38$0.3546$0.35821.89M
Oct 7, 2026$0.3285$0.39$0.3255$0.38433.68M
Oct 6, 2026$0.3699$0.3781$0.3207$0.33172.32M
Oct 5, 2026$0.359$0.3834$0.353$0.372.94M
Oct 2, 2026$0.36$0.405$0.34$0.34764.08M
Oct 1, 2026$0.3151$0.3599$0.3129$0.35593.18M

Latest HRTX news

The latest Smart Investors Daily articles mentioning HRTX.

Stock researchCompany · Overview

HRTX research

Overview

Company profile and research snapshot.

Company profile

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$6.67
Implied upside
—
Analysts
—
HRTX recent ratings
DateFirmRatingTarget
Aug 11, 2026HC Wainwright & Co.Neutral—
Jun 3, 2026HC Wainwright & Co.Buy—
Jun 3, 2026NeedhamHold—
Jan 9, 2026HC Wainwright & Co.Buy—
Aug 8, 2025NeedhamBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 27, 2026

Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026

CARY, N.C., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) (“Heron” or the “Company”), a commercial-stage biotechnology company, today announced that the Company will host a conference call and live webcast on Monday, November 9, 2026, at 8:30 a.m. ET to report third quarter financial results and discuss recent business highlights. The conference call can be accessed by phone by utilizing the following registration link which will provide participants with dial-in deta

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By